MTOR and non-small cell lung carcinoma: To further explore the relationship between PD-L1 and mTOR activity in lung cancer cells, we treated three NSCLC cell lines in which PD-L1 is highly expressed—H157, H1975, and HCC827 [14]—with rapamycin for 24 hours.